医疗保险受益人中即时序贯双侧白内障手术的趋势、相关因素与结局
该回顾性队列研究分析2011至2019年医疗保险按服务收费索赔数据,比较即时序贯双侧白内障手术(ISBCS)与延迟序贯双侧白内障手术(DSBCS)的发生率及相关因素。共识别4014例(0.2%)ISBCS和1940965例(99.8%)DSBCS患者,ISBCS使用率总体较低,但眼内炎和囊样黄斑水肿(CME)发生率与DSBCS相当。种族、地理、全身及眼部合并症与接受ISBCS相关。
要点
- 2011至2019年医疗保险受益人中ISBCS仅占0.2%(4014例),DSBCS占99.8%(1940965例)。
- 黑种人、亚洲人、美洲原住民、农村地区、医院手术、双侧复杂白内障及较高CCI与更可能接受ISBCS相关。
- 青光眼、黄斑变性、黄斑裂孔或视网膜前膜患者接受ISBCS的可能性较低。
核心结论
- 过去十年医疗保险受益人中ISBCS总体使用率仍然较低,但眼内炎和CME发生率与DSBCS相当。
- 种族、地理、全身及眼部合并症与接受ISBCS相关。
- ISBCS可能为改善白内障手术可及性提供潜在机会。
研究设计与样本
- 回顾性队列研究,基于2011至2019年100%医疗保险按服务收费承运方索赔数据的人群分析。
- 研究对象为年龄≥65岁、接受ISBCS和DSBCS的医疗保险受益人。
- 采用逻辑回归模型评估与ISBCS相关的因素。
主要发现
- 共识别4014例(0.2%)ISBCS和1940965例(99.8%)DSBCS患者。
- 黑种人(OR 2.31,95%CI 2.06-2.59)、亚洲人(OR 1.82,95%CI 1.51-2.19)和美洲原住民(OR 2.42,95%CI 1.81-3.23)患者较白种人更可能接受ISBCS。
- 农村地区患者较都市地区患者更可能接受ISBCS(OR 1.26,95%CI 1.17-1.35)。
- 在医院手术较门诊手术更可能接受ISBCS(OR 2.71,95%CI 2.53-2.89);双侧复杂白内障较非复杂白内障更可能接受ISBCS(OR 3.23,95%CI 2.95-3.53)。
- CCI为1-2(OR 1.45,95%CI 1.29-1.62)、3-4(OR 1.70,95%CI 1.47-1.97)、5-6(OR 1.97,95%CI 1.62-2.39)及≥7(OR 1.97,95%CI 1.55-2.50)者较CCI为0者更可能接受ISBCS;青光眼(OR 0.82,95%CI 0.76-0.89)、黄斑变性(OR 0.75,95%CI 0.68-0.82)、黄斑裂孔或视网膜前膜(OR 0.55,95%CI 0.48-0.65)患者接受ISBCS的可能性较低。
关键数值与推荐
- 42天内眼内炎发生率:ISBCS为1.74/1000例手术,DSBCS为1.01/1000例手术,累积比较无显著差异(P=0.15)。
- CME发生率:ISBCS为1.79/100例手术,DSBCS为1.96/100例手术,累积比较无显著差异(P=0.45)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the incidence of immediate sequential bilateral cataract surgery (ISBCS) and delayed sequential bilateral cataract surgery (DSBCS) and to identify factors associated with undergoing ISBCS. DESIGN: Retrospective cohort study. PARTICIPANTS: Medicare beneficiaries aged ≥ 65 who underwent ISBCS and DSBCS from 2011 through 2019. METHODS: Population-based analysis of the 100% Medicare fee-for-service carrier claims data. Logistic regression models were performed to evaluate factors associated with ISBCS. MAIN OUTCOME MEASURES: Incidence of ISBCS and DSBCS; demographic, ocular, and medical characteristics associated with receipt of ISBCS; and rates of endophthalmitis and cystoid macular edema (CME) after ISBCS or DSBCS. RESULTS: A total of 4014 (0.2%) ISBCS and 1 940 965 (99.8%) DSBCS patients were identified. Black (odds ratio [OR], 2.31; 95% confidence interval [CI], 2.06-2.59), Asian (OR, 1.82; 95% CI, 1.51-2.19), and Native American (OR, 2.42; 95% CI, 1.81-3.23) patients were more likely to receive ISBCS than White patients. Patients residing in rural areas showed a higher likelihood of ISBCS (OR, 1.26; 95% CI, 1.17-1.35) than patients in metropolitan areas. Patients undergoing surgery at a hospital, compared with an ambulatory setting (OR, 2.71; 95% CI, 2.53-2.89), were more likely to receive ISBCS. Patients with bilateral complex versus noncomplex cataract (OR, 3.23; 95% CI, 2.95-3.53) were more likely to receive ISBCS. Patients with a Charlson comorbidity index (CCI) of 1 to 2 (OR, 1.45; 95% CI, 1.29-1.62), 3 to 4 (OR, 1.70; 95% CI, 1.47-1.97), 5 to 6 (OR, 1.97; 95% CI, 1.62-2.39), and CCI ≥ 7 (OR, 1.97; 95% CI, 1.55-2.50) were more likely to receive ISBCS than those with a CCI of 0. In contrast, patients with glaucoma (OR, 0.82; 95% CI, 0.76-0.89), macular degeneration (OR, 0.75; 95% CI, 0.68-0.82), and macular hole or epiretinal membrane (OR, 0.55; 95% CI, 0.48-0.65) were less likely to undergo ISBCS than those without. Cumulatively, no significant difference was found in endophthalmitis rates within 42 days between ISBCS (1.74 per 1000 ISBCS procedures) and DSBCS (1.01 per 1000 DSBCS procedures; P = 0.15). Similarly, there was no significant cumulative difference between CME rates (P = 0.45) in ISBCS (1.79 per 100 ISBCS procedures) and DSBCS (1.96 per 100 DSBCS procedures). CONCLUSIONS: Overall use of ISBCS among Medicare beneficiaries remained low over the past decade, although rates of endophthalmitis and CME were comparable to DSBCS. Race, geography, and systemic and ocular comorbidities were associated with receiving ISBCS. ISBCS represents a potential opportunity to improve access to cataract surgery.
引用
- Malwankar J, Son HS, Chang DF, et al. Trends, Factors, and Outcomes Associated with Immediate Sequential Bilateral Cataract Surgery among Medicare Beneficiaries. Ophthalmology. 2021. PMID: 34971649. doi:10.1016/j.ophtha.2021.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。